ADSTEM(Plerixafor injection)
Therapeutic class: hematopoietic stem cell mobilizer
Indication: In combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM).
- 24 mg/1.2 mL (20 mg/mL) single dose vial
- For subcutaneous injection only
- Below 25°C , Shelf Life: 2 Years
- As directed by the physician
